Full Text
Health-Economic Comparison of a Gnrh-Antagonist (Degarelix) Vs. Gnrh-Agonists Considering the Number-Needed-to-Treat to Avoid Cardiovascular Events

Abstract

Authors

D Anderson V Donatz S Vosgerau

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×